Clinical Trials Directory

Trials / Completed

CompletedNCT02438813

Condition of Submental Fullness and Treatment Outcomes Registry

CONTOUR: Condition of Submental Fullness and Treatment Outcomes Registry (A Registry of Submental Fullness, Treatment Options Administered, and Associated Outcomes)

Status
Completed
Phase
Study type
Observational
Enrollment
1,029 (actual)
Sponsor
Kythera Biopharmaceuticals · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The primary objective of this registry is to develop a comprehensive understanding of the condition of submental (SM) fullness due to submental fat (SMF), how it is treated in current clinical practice, and the risks and benefits associated with its treatment.

Conditions

Interventions

TypeNameDescription
DRUGDeoxycholic acidDeoxycholic acid (ATX-101) injection as the treatment of SMF as per standard of care in clinical practice.
PROCEDURESurgical ProceduresSurgical procedures for treatment of SMF as per standard of care in clinical practice.
PROCEDURELaser LiposuctionLaser Liposuction for the treatment of SMF as per standard of care in clinical practice..
DEVICEEnergy DevicesEnergy Devices for the treatment of SMF as per standard of care in clinical practice.
OTHEROther TreatmentsOther treatments for SMF as per standard of care in clinical practice.

Timeline

Start date
2015-05-11
Primary completion
2016-11-10
Completion
2016-11-10
First posted
2015-05-08
Last updated
2018-10-05
Results posted
2018-10-05

Locations

95 sites across 2 countries: United States, Canada

Source: ClinicalTrials.gov record NCT02438813. Inclusion in this directory is not an endorsement.